CCR5 blockade for neuroinflammatory diseases--beyond control of HIV

Nature Reviews. Neurology
Guillaume Martin-BlondelRoland S Liblau

Abstract

Chemokine receptors have been implicated in a wide range of CNS inflammatory diseases and have important roles in the recruitment and positioning of immune cells within tissues. Among them, the chemokine (C-C motif) receptor 5 (CCR5) can be targeted by maraviroc, a readily available and well-tolerated drug that was developed for the treatment of HIV. Correlative evidence implicates the CCR5-chemokine axis in multiple sclerosis, Rasmussen encephalitis, progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome, and infectious diseases, such as cerebral malaria and HIV-associated neurocognitive disorders. On the basis of this evidence, we postulate in this Review that CCR5 antagonists, such as maraviroc, offer neuroprotective benefits in settings in which CCR5 promotes deleterious neuroinflammation, particularly in diseases in which CD8(+) T cells seem to play a pivotal role.

References

May 1, 1997·Nature Genetics·J J MartinsonJ B Clegg
Apr 4, 1998·The Journal of Experimental Medicine·F SallustoA Lanzavecchia
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·O MeucciR J Miller
Mar 17, 1999·The Journal of Clinical Investigation·T L SørensenR M Ransohoff
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·K E BalashovW W Hancock
Oct 26, 1999·Journal of Acquired Immune Deficiency Syndromes : JAIDS·G T NguyêñT R O'Brien
Jan 8, 2000·Journal of Neuroimmunology·F SellebjergP Garred
Jul 11, 2000·Journal of Neuropathology and Experimental Neurology·J A Shukaliak, K Dorovini-Zis
Mar 29, 2001·Nature Immunology·S A Luther, J G Cyster
Nov 6, 2001·Annals of Internal Medicine·J P IoannidisUNKNOWN International Meta-Analysis of HIV Host Genetics
Jan 5, 2002·Journal of Neuroimmunology·S V WestmorelandA A Lackner
Jan 16, 2002·Current Opinion in Immunology·Andrew D Luster
Feb 7, 2002·Blood·Anneline NansenAllan Randrup Thomsen
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katsuhiko FukadaMasafumi Takiguchi
Apr 6, 2002·Acta Neuropathologica·Fabián BernalTeresa Ribalta
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·William G GlassThomas E Lane
Apr 22, 2004·Journal of Neuropathology and Experimental Neurology·Jacqueline Quandt, Katerina Dorovini-Zis
May 4, 2004·Annals of Tropical Medicine and Parasitology·B Y SarfoJ K Stiles
May 6, 2004·Multiple Sclerosis : Clinical and Laboratory Research·J A SilversidesC A Graham
Sep 1, 2004·Cellular Signalling·Martin Oppermann
Apr 12, 2005·Nature Immunology·Barbara MolonAntonella Viola
Oct 12, 2005·PLoS Biology·John NovembreMontgomery Slatkin
Oct 19, 2005·The Journal of Experimental Medicine·William G GlassPhilip M Murphy
Jan 19, 2006·The Journal of Experimental Medicine·William G GlassPhilip M Murphy
Feb 6, 2007·Journal of Neuroimmunology·Andréa Alice SilvaJoseli Lannes-Vieira
May 16, 2007·Annals of Neurology·Jan BauerChristian G Bien

❮ Previous
Next ❯

Citations

May 18, 2016·Current HIV/AIDS Reports·Phillip ChanVictor Valcour
Aug 25, 2016·BioMed Research International·Fu-Chao LiuHuang-Ping Yu
Oct 30, 2016·Expert Opinion on Investigational Drugs·Michelle B KimLawrence J Wilson
Mar 11, 2017·Neurochemistry International·Emilia LaudatiLucia Lisi
Jan 11, 2017·Drugs·A CalcagnoS Bonora
Nov 7, 2017·International Journal of Molecular Sciences·Norikazu KiguchiShiroh Kishioka
Sep 30, 2017·Viruses·Koollawat ChupraditChatchai Tayapiwatana
Jan 25, 2018·Current HIV/AIDS Reports·Andrea CalcagnoStefano Bonora
Jan 7, 2020·Expert Opinion on Drug Metabolism & Toxicology·Miao MiaoGuangdi Li
Dec 6, 2019·Science Translational Medicine·Amanda S Woodward DavisMartin Prlic
Apr 24, 2020·Investigative Ophthalmology & Visual Science·Marie Krogh NielsenTorben Lykke Sørensen
Aug 5, 2019·Cellular and Molecular Life Sciences : CMLS·Laura FantuzziLucia Lopalco
Apr 5, 2019·JCI Insight·Lidia YshiiRoland Liblau
Aug 27, 2019·Frontiers in Aging Neuroscience·Tianwen Li, Jianhong Zhu
Mar 23, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Wei ZhouXingyu Zhang
Aug 20, 2019·Neurological Research and Practice·Maria-Ioanna StefanouMarkus C Kowarik
Mar 11, 2021·Seminars in Neurology·Mary Teena Joy, S Thomas Carmichael
Apr 19, 2021·Journal of Translational Medicine·Nerea Cuesta-GomezJohn D M Campbell
May 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Maelig G MorvanJay A Levy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here